Thomas Reilly
2020
In 2020, Thomas Reilly earned a total compensation of $1.6M as Chief Financial Officer at Cara Therapeutics.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Option Awards | $1,417,868 |
| Salary | $100,000 |
| Other | $590 |
| Total | $1,588,458 |
Reilly received $1.4M in option awards, accounting for 89% of the total pay in 2020.
Reilly also received $70K in bonus, $100K in salary and $590 in other compensation.
Rankings
In 2020, Thomas Reilly's compensation ranked 6,588th out of 13,090 executives tracked by ExecPay. In other words, Reilly earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,588 out of 13,090 | 50th |
Division Manufacturing | 2,732 out of 5,624 | 51st |
Major group Chemicals And Allied Products | 1,101 out of 2,257 | 51st |
Industry group Drugs | 955 out of 1,957 | 51st |
Industry Pharmaceutical Preparations | 714 out of 1,462 | 51st |
Source: SEC filing on April 23, 2021.
Reilly's colleagues
We found four more compensation records of executives who worked with Thomas Reilly at Cara Therapeutics in 2020.